Navigation Links
Optima L-XP 60/50 Hz, 220-240 VAC

ProductsOptima L-XP 60/50 Hz, 220-240 VAC
Company Beckman Coulter, Inc.
Item Optima L-XP 60/50 Hz, 220-240 VAC
Features Advanced Optima eXPert software provides unprecedented centrifugation capabilities. It assists in developing the most efficient centrifugation methods, selecting the rotor and labware for a given application, then simulating the results before performing separations of proteins and sub-cellular particles. The innovative rotors built for the Optima L-XP are designed, manufactured and tested as a system from the inside out to get the highest quality of separation in the shortest possible time-safely and reliably. The increased efficiency of SW 32 Ti series rotors can reduce run times. The patented NVT rotors deliver the highest purity in the shortest possible time. Optima L-XP utilizes the most advanced materials and technology to achieve the high performance needed for extending the boundaries of research. And the imbalance-tolerant Optima L-XP drive safely accommodates tubes that are under- or over-filled by as much as 10%. The design of one-touch OptiSeal tubes delivers fast, reliable sealing--just insert the plug and press into place, and the centrifugation process itself provides guaranteed protection for samples.
Description Optima L-XP ultracentrifuge is designed to play a key role in the discovery process if research involves proteomics, cytomics or genomics. It has a sophisticated on-board computer, enhanced firmware, powerful Optima eXPert software and an easy-to-use touch screen, Optima L-XP delivers superior functionality, optimized user efficiencies, far greater capabilities and faster turnarounds than any other ultracentrifuge.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. Optima Toric
2. Optima FW
3. Optima 38/SP
4. Optima L-XP 50 Hz, 220-240 VAC
5. Optima L-90 K Ultracentrifuge 50 Hz, 220-240 VAC
6. Optima L-90 K Ultracentrifuge 60/50 Hz, 220-240 VAC
7. Optima LE-80 K Ultracentrifuges 60/50 Hz, 220-240 VAC
8. Optima LE-80 K Ultracentrifuges 50 Hz, 220-240 VAC
9. OptimaMAX Ultracentrifuges 110 VAC 60 Hz
10. OptimaMAX-E Ultracentrifuges 110 VAC 60 Hz
11. Optima Stem
TAG: Optima VAC
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products:
(Date:10/7/2008)...es, Mfg. is pleased to announce the introduction o...re exclusively available from Industrial Specialti...ct style fittings integrated into the Celcon plast...rs versatility and customization for a variety of ...ctober 7, 2008 -- Exclusively available from http:...
(Date:10/7/2008)... Bull - expert in open,flexible and secure inform...urope,s leading players in the IT industry - annou...acquisition of its Medicaid solutions,business, ma... management,in the United States by Ingenix, a lea... services company. These operations provide Medica...
(Date:10/6/2008)... effects can affect length of stay, study says , ...mple changes to hospital procedures can significan...on opiates to relieve pain, a new study reveals. ...4 U.S. children,s hospitals, documented a 67 perce... relievers under these new procedures. , The s...
(Date:10/6/2008)...stion that Halloween is a particularly frightening...l kids want to join in the fun of trick or treatin...n…as long as they steer clear of the foods ... SCHILLER PARK, Ill. (Business Wire EON) Octob...der in allergy-friendly and gluten-free foods, tea...
Breaking Medicine News(10 mins):Health News:Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix 2Health News:Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix 3Health News:Hospital Fixes Cut Opiate Errors in Kids 2Health News: Enjoy Life Foods Teams with AllergyMoms.com to Ensure Halloween Isn't 'Tricky' for Food-Allergic Kids and Families : Provides tips for being allergy-aware this Halloween 2Health News: Enjoy Life Foods Teams with AllergyMoms.com to Ensure Halloween Isn't 'Tricky' for Food-Allergic Kids and Families : Provides tips for being allergy-aware this Halloween 3Health News: Enjoy Life Foods Teams with AllergyMoms.com to Ensure Halloween Isn't 'Tricky' for Food-Allergic Kids and Families : Provides tips for being allergy-aware this Halloween 4
...archers have found that people with a bad tooth ha...seases. Dr. Barbara Taylor, Dentist and Geoffrey T...cientists from University of Oslo, Norway have fou...art diseases such as strokes and heart attacks. Gu...
...-Cal coverage was given to poor residents of Calif...i-Cal coverage reimbursements given to the doctors...This has raised a lot of doubts and questions abou...have stated to avoid treating these patients and t...
...udy has been published by Alcoholism: Clinical and...sing the prices of alcoholic drinks does not resul...ards drinkers going in for cheaper and inferior li...board price increases may not always have the inte...
...ious claims that statins might reduce the risk of ... the first 27 trials of statins// for cardiovascul...d found no reduced incidence of colorectal cancers...cers in people who took the drugs when compared wi...
Other Medicine News:Health News:Slash In Medi-Cal Coverage Makes Medical Care For The Poor Questionable 2Health News:Price Of Alcohol Does Not Influence Consumption 2Health News:Counter study: cholesterol drugs no good in preventing colon cancer 2
(Date:10/7/2008)...re-FirstCall/ - Burcon NutraScience,Corporation (T...,Supertein(TM) canola protein isolates are GRAS (G...e in a variety of food and beverage,applications. ...an,independent evaluation by a panel of qualified ...nutritional sciences, food allergies and pediatric...
(Date:10/7/2008)...wire-FirstCall/ -- CEL-SCI Corporation,(NYSE: CVM...rial Transfer,Agreement (MTA) with the National In... laboratory of Dr. Francesco M. Marincola, M.D., t...e tumor microenvironment,caused by CEL-SCI,s cance...e Infectious Disease and Immunogentics Section, De...
(Date:10/7/2008)... /- A study published in the,scientif...lf-renewal,reported that InVitria,s ( http://www....albumin) was an effective replacement to bovine se...tled, "The ground state of embryonic stem cell,sel...tim as a recombinant,albumin in place of animal-de...
(Date:10/7/2008)...RNewswire/ -- Taligen Therapeutics Inc.,today anno...s pipeline,candidates were presented at the XXII I...land. The data highlighted the candidates, efficac...diseases., "These highlighted presentations, as w...onference, reveal the deep expertise and expanding...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 1443 1NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 1443 2Home Care Agencies Responding to Patients Needs Still Have Room for Improvement 1441 1Home Care Agencies Responding to Patients Needs Still Have Room for Improvement 1441 2First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 1First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 2First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 3First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 4First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 5First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 6First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 7First Osteoporosis Study in Hip Fracture Patients Finds Once Yearly Reclast 28R 29 Prevents Additional Fractures and Improves Survival 288 8Directors Forum 3A PEPFAR and the Global AIDS Response 286 1Directors Forum 3A PEPFAR and the Global AIDS Response 286 2
...om placebo,controlled phase IIa study in patients ...N (Zurich), Switzerland, May 15, 2007 - Cytos Biot...sults from a multi-centre,and placebo-controlled p...03-QbG10, an immunotherapeutic product candidate f...ncluded 40 patients,suffering from mild to moderat...
...07 - Synthetic Blood,International, Inc. (OTCBB:SY...al analysis of its Phase IIa study with Oxycyte(TM... with preliminary,study results announced in Decem...rimary endpoint of increasing patients, oxygen,ten...lso show a,decrease in patient glucose and lactate...
Other Medicine Technology:Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3